UK markets open in 6 hours 14 minutes

Many Bright Ideas Technologies Inc. (MBGNF)

Other OTC - Other OTC Delayed price. Currency in USD
Add to watchlist
0.01000.0000 (0.00%)
At close: 09:52AM EDT

Many Bright Ideas Technologies Inc.

598 East Kent Avenue South
Vancouver, BC V5X 4V6
Canada
604-732-7332
https://www.medbiogene.com

Sector(s)Healthcare
IndustryDiagnostics & Research
Full-time employees

Key executives

NameTitlePayExercisedYear born
Dr. Iain Weir-Jones FGS, P.Eng., Ph.D.President, Chairman & CEON/AN/AN/A
Mr. Ibrahim GhobrialCFO & CS9.23kN/AN/A
Amounts are as of 31 December 2022, and compensation values are for the last fiscal year ending on that date. Pay includes salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.

Description

Many Bright Ideas Technologies Inc. does not have significant operations. Previously, the company was engaged in the life science business with a focus on the development and commercialization of genomic-based tests for non-small-cell lung cancer. It focuses on the commercialization of technologies in various industrial sectors. The company was formerly known as Med BioGene Inc. and changed its name to Many Bright Ideas Technologies Inc. in June 2022. The company was incorporated in 2006 and is headquartered in Vancouver, Canada.

Corporate governance

Many Bright Ideas Technologies Inc.’s ISS governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while 10 indicates higher governance risk.